Blue Heron Invests in Redi Health’s Innovative Digital Solutions
Key Highlights $14M Series B funding led by Blue Heron Capital, supporting Redi Health’s mission to transform patient support…
Browsing Tag
Rev1 Ventures
2 posts
Clarametyx Biosciences Secures $33M in Series A Funding to Propel Anti-Biofilm Technology
Key Highlights Clarametyx Biosciences Inc. secures $33 million in Series A funding, targeting persistent infections associated with biofilms. Funds…